| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_fd301d90f320fb51821c18f962bee0e2 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0056
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-42 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-68 |
| filingDate |
2004-11-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2009-10-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_19696aa83fb0b463cd96ec1cd9ae4f4d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c984b51b202e866a35209000802bc101
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f91e68238f1036558fa4792ae30ba71b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a02ec73822f5d73aa57f3909c749785e |
| publicationDate |
2009-10-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
RU-2369379-C2 |
| titleOfInvention |
Non-tableted chewable dosing medicines for individual use |
| abstract |
FIELD: medicine. ^ SUBSTANCE: according to the invention, there is provided non tableted chewable dosing medicines for individual use containing composition comprising at least one pharmaceutically active substance dissolved or dispersed in the matrix material containing not less than 0.2 wt % of gelatine, at least one stabilising agent and at least one water soluble spirit and/or water as resolvent. The composition is plastic at a high temperature with stabilising agent selected from the group comprising (i) glycerin asters and fatty acid esters; (and) products resulted from a reaction of alcoholysis/esterification of the said glycerin and fatty acid esters with polyethyleneglycol; and melting temperature range of stabilising agent is within 42 to 63C, water content is not more than 46 wt % in terms of composition. ^ EFFECT: medicine use efficiency upgrading. ^ 22 cl, 7 ex |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EA-021368-B1 |
| priorityDate |
2003-11-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |